Volume 3, Issue 1

March 2003

7 articles in this issue

Biotechnology-derived cardiovascular therapeutics and toxicity
Y. James
BriefCommunication Pages: 1 - 3
Commercial development considerations for biotechnology-derived therapeutics
B. J. Marafino Jr.
M. K. Pugsley
OriginalPaper Pages: 5 - 12
Direct thrombin inhibitors in cardiac disease
Jeffrey I. Weitz
Eric R. Bates
OriginalPaper Pages: 13 - 25
Translation of PDGF cardioprotective pathways
Jay M. Edelberg
Dongqing Cai
Munira Xaymardan
OriginalPaper Pages: 27 - 35
Nesiritide
Alan S. Maisel
OriginalPaper Pages: 37 - 42
Inhibitors of the complement system currently in development for cardiovascular disease
M. K. Pugsley
M. Abramova
W. S. Ammons
OriginalPaper Pages: 43 - 69
Adenosine receptors and cardiovascular disease
E. S. Hayes
OriginalPaper Pages: 71 - 88

Search